Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP910853.RACeTA16ZgjrVtgRThOwGltg8A3KwrT86x-unox4rgvoY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP910853.RACeTA16ZgjrVtgRThOwGltg8A3KwrT86x-unox4rgvoY130_assertion type Assertion NP910853.RACeTA16ZgjrVtgRThOwGltg8A3KwrT86x-unox4rgvoY130_head.
- NP910853.RACeTA16ZgjrVtgRThOwGltg8A3KwrT86x-unox4rgvoY130_assertion description "[Expression of LPA2 or LPA3 during ovarian carcinogenesis contributes to ovarian cancer aggressiveness, suggesting that the targeting of LPA production and action may have potential for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP910853.RACeTA16ZgjrVtgRThOwGltg8A3KwrT86x-unox4rgvoY130_provenance.
- NP910853.RACeTA16ZgjrVtgRThOwGltg8A3KwrT86x-unox4rgvoY130_assertion evidence source_evidence_literature NP910853.RACeTA16ZgjrVtgRThOwGltg8A3KwrT86x-unox4rgvoY130_provenance.
- NP910853.RACeTA16ZgjrVtgRThOwGltg8A3KwrT86x-unox4rgvoY130_assertion SIO_000772 19001604 NP910853.RACeTA16ZgjrVtgRThOwGltg8A3KwrT86x-unox4rgvoY130_provenance.
- NP910853.RACeTA16ZgjrVtgRThOwGltg8A3KwrT86x-unox4rgvoY130_assertion wasDerivedFrom befree-20140225 NP910853.RACeTA16ZgjrVtgRThOwGltg8A3KwrT86x-unox4rgvoY130_provenance.
- NP910853.RACeTA16ZgjrVtgRThOwGltg8A3KwrT86x-unox4rgvoY130_assertion wasGeneratedBy ECO_0000203 NP910853.RACeTA16ZgjrVtgRThOwGltg8A3KwrT86x-unox4rgvoY130_provenance.